Press/Pulse: A Sustainable Approach to Managing Cancer
Emerging evidence suggests that cancer, regardless of its tissue of origin, is fundamentally a metabolic mitochondrial disease, rather than a disease of somatic mutation. This understanding has led to increased interest in metabolic therapies, including Dr. Thomas Seyfried's Press/Pulse protocol, as a non-toxic and sustainable approach to managing tumour burden.
The Press/Pulse protocol targets the key metabolic pathways that cancer cells rely on for energy production, specifically the fermentation of glucose and glutamine. By chronically lowering glucose availability while providing non-fermentable ketone bodies, the protocol aims to degrade tumour viability and extend survivorship.
Participation in the coherent and effective implementation of Press/Pulse via independent, patient driven administration, is demonstrably extending survivorship beyond what the Standard of Care alone can offer. Successful application of dietary ketogenic metabolic therapy in patients with glioblastoma: a clinical study
Working in a collaborative and supportive environment to explore the key elements of metabolic therapies helps you navigate the challenges of implementation with ongoing support and guidance.
the press/pulse protocol
To press and to pulse
Based on the understanding that the common phenotype of all cancers is an energetic reliance on the fermentation of glucose and glutamine due to the loss or inhibition of normative cellular respiration in the form of oxidative phosphorylation, Press/Pulse targets these key metabolic pathways, degrading tumour viability.
Press/ Pulse is a term borrowed from paleo biology; a Press disturbance is one that shifts the adaptive landscape and a Pulse disturbance is an acute event that disrupts biological functions to produce high mortality. We consider the Press/ Pulse concept in light of current views on the origin of cancer.
- Press: Sustained reduction of glucose availability through a controlled ketogenic diet, whereby the body relies on ketones for energy, which cancer cells cannot ferment into ATP. This phase also includes mebendazole, an antiparasitic drug that has been shown to inhibit cancer cell growth, and stress management techniques, as chronic stress can elevate glucose levels and fuel cancer metabolism.
- Pulse: Periodic, targeted interventions that include glutamine inhibition and hyperbaric oxygen therapy. Restricting availability of cancer’s secondary fuel source—glutamine and create metabolic stress. Hyperbaric oxygen therapy (HBOT)further amplifies this stress by flooding cancer cells with oxygen, upregulating reactive oxygen species. This leads to increased oxidative stress, pushing cancer cells closer to death while leaving healthy cells unharmed.
By combining these strategies, the protocol disrupts cancer’s energy supply, weakens tumor cells, and enhances the body’s natural ability to fight disease, while protecting healthy cells.
CALL TO ACTION
- Explore the Press/Pulse protocol further and consider its potential benefits for yourself or your loved ones.
- Connect with Kathryn Grace For personalized guidance and support in implementing the Press/Pulse protocol.
- Join the growing community embracing metabolic therapies as a path toward a healthier future.